No evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer families

European Journal of Cancer

Volumn 39, Issue 3, 2003, Pages 366-371

  Karppinen, S M ^a   Vuosku, J ^a   Heikkinen, K ^a   Allinen, M ^a   Winqvist, R ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Germline BACH1 mutations; Hereditary breast and ovarian cancer

Indexed keywords

ALLELE; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; EXON; FEMALE; GEL ELECTROPHORESIS; GENE SEQUENCE; GENETIC POLYMORPHISM; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATION; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DNA BINDING;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BREAST NEOPLASMS; DNA, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; FINLAND; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MUTATION, MISSENSE; OVARIAN NEOPLASMS; PEDIGREE; TRANSCRIPTION FACTORS;

EID: 0037306114     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00498-7     Document Type: Article

References (37)

1. Claus E.B., Schildkraut J.M., Thompson W.D., Risch N.J. The genetic attributable risk of breast and ovarian cancer. Cancer. 77:1996;2318-2324.
2. Rahman N., Stratton M.R. The genetics of breast cancer susceptibility. Annu. Rev. Genet. 32:1998;95-121.
3. Miki Y., Swensen J., Shattuck-Eidens D.et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
4. Wooster R., Bignell G., Lancaster J.et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
5. Serova O.M., Mazoyer S., Puget N.et al. Mutations in BRCA1 and BRCA2 in breast cancer families. are there more breast cancer-susceptibility genes? Am. J. Hum. Genet. 60:1997;486-495.
6. Vehmanen P., Friedman L.S., Eerola H.et al. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families. evidence for additional susceptibility genes Hum. Mol. Genet. 6:1997;2309-2315.
7. Ford D., Easton D.F., Stratton M.et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet. 62:1998;676-689.
8. Vehmanen P., Friedman L.S., Eerola H.et al. A low proportion of BRCA2 mutations in Finnish breast cancer families. Am. J. Hum. Genet. 60:1997;1050-1058.
9. Huusko P., Pääkkönen K., Launonen V.et al. Evidence of founder mutations in Finnish BRCA1 and BRCA2 families. Am. J. Hum. Genet. 62:1998;1544-1548.
10. Lahti-Domenici J., Rapakko K., Pääkkönen K.et al. Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families. Cancer Genet. Cytogenet. 129:2001;120-123.
11. Nathanson K.L., Weber B.L. "Other" breast cancer susceptibility genes. searching for more holy grail Hum. Mol. Genet. 10:2001;715-720.
12. Nathanson K.N., Wooster R., Weber B.L. Breast cancer genetics. what we know and what we need Nat. Med. 7:2001;552-556.
13. Kerr P., Ashworth A. New complexities for BRCA1 and BRCA2. Curr. Biol. 11:2001;R668-R676.
14. Liu Y., West S.C. Distinct functions of BRCA1 and BRCA2 in double-strand break repair. Breast Cancer Res. 4:2002;9-13.
15. Cantor S.B., Bell D.W., Ganesan S.et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell. 105:2001;149-160.
16. van Brabant A.J., Stan R., Ellis N.A. DNA helicases, genomic instability, and human genetic disease. Annu. Rev. Genomics Hum. Genet. 1:2000;409-459.
17. Koonin E.V., Altschul S.F., Bork P. BRCA1 protein products functional motifs. Nature Genet. 13:1996;266-268.
18. Monteiro A.N., August A., Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA. 93:1996;13595-13599.
19. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11:1997;68-76.
20. Callebaut I., Mornon J.-P. From BRCA1 to RAP1. a widespread BRCT module closely associated with DNA repair FEBS Lett. 400:1997;25-30.
21. Ouchi T., Monteiro A.N., August A., Aaronson S.A., Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. USA. 95:1998;2302-2306.
22. Moynahan M.E., Chiu J.W., Koller B.H., Jasin M. Brca1 controls homology-directed DNA repair. Mol. Cell. 4:1999;511-518.
23. Scully R., Ganesan S., Vlasakova K., Chen J., Socolovsky M., Livingston D.M. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell. 4:1999;1093-1099.
24. Callahan R. Somatic mutations that contribute to breast cancer. Biochem. Soc. Symp. 63:1998;211-221.
25. Chen K.C., Hsieh T.T., Schwartz P.E., Yang-Feng T.L. Allelic deletion mapping of putative tumor suppressor genes on 17q in sporadic ovarian cancer. J. Obstet. Gynaecol. 21:1995;619-624.
26. Ghimenti C., Sensi E., Presciuttini S.et al. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations. Genes Chromosomes Cancer. 33:2002;235-242.
27. Allinen M., Huusko P., Mäntyniemi S., Launonen V., Winqvist R. Mutation analysis of the CHK2 gene in families with hereditary breast cancer. Br. J. Cancer. 85:2001;209-212.
28. Rapakko K., Allinen M., Syrjäkoski K.et al. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites. Br. J. Cancer. 84:2001;116-119.
29. Körkkö J., Annunen S., Pihlajamaa T., Prockop D.J., Ala-Kokko L. Conformation sensitive gel electrophoresis for simple and accurate detection of mutations. comparison with denaturing gradient gel electrophoresis and nucleotide sequencing Proc. Natl. Acad. Sci. USA. 95:1998;1681-1685.
30. Luo L., Lei H., Du Q.et al. No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast-cancer families linked to 17q22. Int. J. Cancer. 98:2002;638-639.
31. Bell D.W., Varley J.M., Szydlo T.E.et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 286:1999;2528-2531.
32. Chenevix-Trench G., Spurdle A.B., Gatei M.et al. Dominant negative ATM mutations in breast cancer families. J. Natl. Cancer Inst. 94:2002;205-215.
33. de Jong M.M., Nolte I.M., te Meerman G.J.et al. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J. Med. Genet. 39:2002;225-242.
34. Scully R., Puget N. BRCA1 and BRCA2 in hereditary breast cancer. Biochimie. 84:2002;95-102.
35. Meijers-Heijboer H., van Den Ouweland A., Klijn J.et al. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet. 31:2002;55-59.
36. Vahteristo P., Tamminen A., Karvinen P.et al. p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome. further evidence of CHK2 in inherited cancer predisposition Cancer Res. 61:2001;5718-5722.
37. Melo J., Toczyski D. A unified view of the DNA-damage checkpoint. Curr. Opin. Cell Biol. 14:2002;237-245.